JPH0581588B2 - - Google Patents

Info

Publication number
JPH0581588B2
JPH0581588B2 JP63108909A JP10890988A JPH0581588B2 JP H0581588 B2 JPH0581588 B2 JP H0581588B2 JP 63108909 A JP63108909 A JP 63108909A JP 10890988 A JP10890988 A JP 10890988A JP H0581588 B2 JPH0581588 B2 JP H0581588B2
Authority
JP
Japan
Prior art keywords
group
formula
compound
dihydropyridine
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP63108909A
Other languages
English (en)
Japanese (ja)
Other versions
JPS63297365A (ja
Inventor
Fureizaa Kyanpuberu Shimon
Jon Hanfurii Maikeru
Sutoobii Aran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of JPS63297365A publication Critical patent/JPS63297365A/ja
Publication of JPH0581588B2 publication Critical patent/JPH0581588B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Dental Preparations (AREA)
JP63108909A 1987-05-02 1988-04-30 ジヒドロピリジン類 Granted JPS63297365A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8710493 1987-05-02
GB878710493A GB8710493D0 (en) 1987-05-02 1987-05-02 Dihydropyridines

Publications (2)

Publication Number Publication Date
JPS63297365A JPS63297365A (ja) 1988-12-05
JPH0581588B2 true JPH0581588B2 (enExample) 1993-11-15

Family

ID=10616773

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63108909A Granted JPS63297365A (ja) 1987-05-02 1988-04-30 ジヒドロピリジン類

Country Status (13)

Country Link
US (1) US4806557A (enExample)
EP (1) EP0290211B1 (enExample)
JP (1) JPS63297365A (enExample)
AT (1) ATE66915T1 (enExample)
CA (1) CA1326672C (enExample)
DE (1) DE3864573D1 (enExample)
DK (1) DK172094B1 (enExample)
ES (1) ES2031595T3 (enExample)
FI (1) FI90415C (enExample)
GB (1) GB8710493D0 (enExample)
GR (1) GR3002767T3 (enExample)
IE (1) IE60055B1 (enExample)
PT (1) PT87361B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270323A (en) * 1990-05-31 1993-12-14 Pfizer Inc. Method of treating impotence
US6057344A (en) * 1991-11-26 2000-05-02 Sepracor, Inc. Methods for treating hypertension, and angina using optically pure (-) amlodipine
ATE248835T1 (de) * 1999-06-25 2003-09-15 Vertex Pharma Prodrugs von impdh-inhibierenden carbamaten
GB0008332D0 (en) * 2000-04-04 2000-05-24 Pfizer Ltd Treament
US6521647B2 (en) 2000-04-04 2003-02-18 Pfizer Inc. Treatment of renal disorders
US6653481B2 (en) 2000-12-29 2003-11-25 Synthon Bv Process for making amlodipine
US7335380B2 (en) 2000-12-29 2008-02-26 Synthon Ip Inc. Amlodipine free base
CA2433193C (en) 2000-12-29 2006-01-31 Pfizer Limited Amide derivative of amlodipine
AT5874U1 (de) 2000-12-29 2003-01-27 Bioorg Bv Pharmazeutische zubereitungen enthaltend amlodipinmaleat
EP1309557B9 (en) 2000-12-29 2006-11-15 Pfizer Limited Amlodipine hemimaleate
EP1309556B1 (en) 2000-12-29 2004-11-24 Pfizer Limited Amlodipine fumarate
WO2002054062A2 (en) 2000-12-29 2002-07-11 Pfizer Limited Reference standards and processes for determining the purity or stability of amlodipine maleate
WO2002053540A1 (en) 2000-12-29 2002-07-11 Pfizer Limited Aspartate derivative of amlodipine as calcium channel antagonist
PL362660A1 (en) 2000-12-29 2004-11-02 Pfizer Limited Process for making amlodipine maleate
MXPA03005882A (es) 2000-12-29 2005-04-19 Pfizer Ltd Derivado amida de amlodipina.
US6699892B2 (en) 2002-06-04 2004-03-02 Yung Shin Pharmaceutical Industrial Co., Ltd. Pharmaceutically acceptable salt of amlodipine and method of preparing the same
KR100538641B1 (ko) * 2002-07-30 2005-12-22 씨제이 주식회사 암로디핀의 유기산염
KR100462304B1 (ko) * 2002-07-30 2004-12-17 씨제이 주식회사 암로디핀의 유기산염
KR100496436B1 (ko) * 2002-07-30 2005-06-20 씨제이 주식회사 암로디핀의 유기산염
KR20040011751A (ko) * 2002-07-30 2004-02-11 씨제이 주식회사 암로디핀의 유기산염
KR100467669B1 (ko) * 2002-08-21 2005-01-24 씨제이 주식회사 암로디핀의 유기산염
BR112012028153A2 (pt) 2010-05-03 2018-08-07 Tsh Biopharm Corporation Ltd composição farmacêutica e método para o tratamento de hipertensão

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552911A (en) * 1975-07-02 1979-09-19 Fujisawa Pharmaceutical Co 1,4 dihydropyridine derivatives and the preparation thereof
US4447613A (en) * 1979-08-24 1984-05-08 Zoecon Corporation Pyridyl esters and thiolesters of aminoalkanoic acids
CS228917B2 (en) * 1981-03-14 1984-05-14 Pfizer Method of preparing substituted derivatives of 1,4-dihydropyridine
DK161312C (da) * 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
GB8306666D0 (en) * 1983-03-10 1983-04-13 Pfizer Ltd Therapeutic agents
US4568677A (en) * 1983-07-23 1986-02-04 Pfizer Inc. 2-(4-Pyrimidone alkoxyalkyl) dihydropyridine anti-ischaemic and antihypertensive agents

Also Published As

Publication number Publication date
ES2031595T3 (es) 1992-12-16
FI882001A7 (fi) 1988-11-03
DK234388D0 (da) 1988-04-28
PT87361B (pt) 1992-08-31
IE881283L (en) 1988-11-02
DE3864573D1 (en) 1991-10-10
FI882001A0 (fi) 1988-04-28
GR3002767T3 (en) 1993-01-25
DK172094B1 (da) 1997-10-20
GB8710493D0 (en) 1987-06-03
FI90415C (fi) 1994-02-10
CA1326672C (en) 1994-02-01
ATE66915T1 (de) 1991-09-15
EP0290211B1 (en) 1991-09-04
FI90415B (fi) 1993-10-29
IE60055B1 (en) 1994-05-18
DK234388A (da) 1989-01-19
EP0290211A1 (en) 1988-11-09
US4806557A (en) 1989-02-21
PT87361A (pt) 1989-05-31
JPS63297365A (ja) 1988-12-05

Similar Documents

Publication Publication Date Title
JPH0581588B2 (enExample)
US5874447A (en) 4-Phenylpiperidine compounds for treating depression
EP1309594B1 (fr) Derives de benzimidazole, leur preparation et leur application en therapeutique
EP1527048B1 (fr) Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
EP0707006A1 (de) Aroyl-piperidin-Derivate
HU187868B (en) Process for producing dihydropyridine derivatives
KR880000180B1 (ko) 디하이드로 피리딘의 제조방법
FR2562892A1 (fr) Nouveaux dihydropyridinyldicarboxylates amides et esters, utilisation de ces composes comme medicament, compositions pharmaceutiques comprenant de tels composes et procede pour la preparation de tels composes
JPWO1993011108A1 (ja) ピペリジン誘導体及びこれを含有する医薬
JP3498849B2 (ja) ニューロキニンａ拮抗剤としての二環式複素環化合物
EP0266989B1 (en) Dihydropyridine anti-allergic and anti-inflammatory agents
US4937242A (en) 1,4-dihydropyridine derivatives and pharmaceutical composition thereof
EP0598123A1 (en) Piperazine derivative and drug containing the same
JP3093419B2 (ja) １，４‐ベンゾチアゼピン誘導体
PT87360B (pt) Satelite duplo com denteado reforcado para articulacao micrometrica utilizada mais especialmente nos bancos de veiculos
AU1619995A (en) New ylidene compounds and process for their preparation
US4495194A (en) Antihypertensive isoindole derivatives
JP3588363B2 (ja) キノキサリンジオン類
US5272161A (en) Indolesulphonamide-substituted dihydropyridines
FI86849B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara azepinonderivat och vid foerfarandet anvaendbara mellanprodukter.
US4600758A (en) Isoindole derivatives
CA1207768A (fr) Carboxamidoguanidines, leur procede d'obtention et les compositions pharmaceutiques en renfermant
JPWO1995033726A1 (ja) ４−キノリノン誘導体又はその塩
US5444077A (en) Ameliorant of cerebral circulation and optical isomer of NB-818, processes for its use
EP0366548A1 (en) Dihydropyridine derivatives